Bio-Rad Laboratories Class B
BIO.B
5 hedge funds and large institutions have $4.03M invested in Bio-Rad Laboratories Class B in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
13% more capital invested
Capital invested by funds: $3.55M → $4.03M (+$478K)
0% more ownership
Funds ownership: 0.58% → 0.58% (+0%)
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$63.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$12K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $3.01M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $884K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $135K | +$63.3K | +493 | +97% |
|
|
FNYS
4
First New York Securities
New York
| $1.49K | – | – | – |
|
|
5
Invesco
Atlanta,
Georgia
| – | -$12K | -96 | Closed |
|
|
BIT
6
BlackRock Institutional Trust
San Francisco,
California
| – | -$5K | -42 | Closed |
|
BIO.B Hedge Fund Activity: Q1 2015 in Review
5 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2015, worth a combined $4.03M — up 13% from $3.55M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIO.B and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $63.3K. The largest seller was Invesco, exiting entirely with an estimated $12K sold.
- 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2015, down from 7 in Q4 2014.
- Funds reported $4.03M of Bio-Rad Laboratories Class B stock for Q1 2015, up 13% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q1 2015 and 2 closed out, a net change of -2 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2015 was UBS Group, an estimated $63.3K added.
- The largest Bio-Rad Laboratories Class B seller in Q1 2015 was Invesco, an estimated $12K sold.
Based on aggregated 13F filings for Q1 2015.